A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Public ClinicalTrials.gov record NCT06613698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults With Alcohol-related Liver Disease (ALD)
Study identification
- NCT ID
- NCT06613698
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 393 participants
Conditions and interventions
Conditions
Interventions
- GSK4532990 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 26, 2024
- Primary completion
- Aug 1, 2027
- Completion
- Mar 6, 2028
- Last update posted
- Mar 31, 2026
2024 – 2028
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Chandler | Arizona | 85224 | Recruiting |
| GSK Investigational Site | Phoenix | Arizona | 85006 | Recruiting |
| GSK Investigational Site | Tucson | Arizona | 85715 | Recruiting |
| GSK Investigational Site | Davis | California | 95817 | Recruiting |
| GSK Investigational Site | Los Angeles | California | 90033 | Recruiting |
| GSK Investigational Site | Los Angeles | California | 90048 | Recruiting |
| GSK Investigational Site | Brandon | Florida | 33511 | Recruiting |
| GSK Investigational Site | Miami Lakes | Florida | 33016 | Recruiting |
| GSK Investigational Site | Atlanta | Georgia | 30309 | Recruiting |
| GSK Investigational Site | Indianapolis | Indiana | 46202 | Recruiting |
| GSK Investigational Site | Topeka | Kansas | 66606 | Recruiting |
| GSK Investigational Site | Marrero | Louisiana | 70072 | Recruiting |
| GSK Investigational Site | Detroit | Michigan | 48202 | Recruiting |
| GSK Investigational Site | Las Vegas | Nevada | 89106 | Recruiting |
| GSK Investigational Site | New York | New York | 10029 | Recruiting |
| GSK Investigational Site | Chapel Hill | North Carolina | 27514 | Recruiting |
| GSK Investigational Site | Cleveland | Ohio | 44195 | Recruiting |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19014 | Recruiting |
| GSK Investigational Site | Arlington | Texas | 76012 | Recruiting |
| GSK Investigational Site | Austin | Texas | 78757 | Recruiting |
| GSK Investigational Site | Dallas | Texas | 75203 | Recruiting |
| GSK Investigational Site | Dallas | Texas | 75235 | Recruiting |
| GSK Investigational Site | Georgetown | Texas | 78626 | Recruiting |
| GSK Investigational Site | McAllen | Texas | 78503 | Completed |
| GSK Investigational Site | San Antonio | Texas | 78215 | Recruiting |
| GSK Investigational Site | Richmond | Virginia | 23219 | Recruiting |
| GSK Investigational Site | Richmond | Virginia | 23249 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06613698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06613698 live on ClinicalTrials.gov.